Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: A controlled study

Journal of the American Academy of Dermatology

Volumn 41, Issue 3, 1999, Pages 431-434

  Bergasa, N V ^a   Alling, D W ^a   Talbot, T L ^a   Wells, M C ^a   Jones, E A ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALMEFENE;

ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; HEPATITIS C; HUMAN; ORAL DRUG ADMINISTRATION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SARCOIDOSIS; SCRATCHING;

EID: 0032841507     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)70117-9     Document Type: Article

References (18)

1. DS Raiford Pruritus of chronic cholestasis Q J Med 88 1995 603 607
2. EA Jones NV Bergasa The pruritus of cholestasis and the opioid system JAMA 268 1992 3359 3362
3. NV Bergasa EA Jones The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids Gastroenterology 108 1995 1582 1588
4. NV Bergasa TL Talbot DW Alling JM Schmitt EC Walker BL Baker A controlled trial of naloxone infusions for the pruritus of chronic cholestasis Gastroenterology 102 1992 544 549
5. NV Bergasa DW Alling TL Talbot MG Swain C Yurdaydin ML Turner Effects of naloxone infusions in patients with the pruritus of cholestasis: a double-blind, randomized, controlled trial Ann Intern Med 123 1995 161 167
6. TM Speight NHG Holford Avery’s drug treatment 4th ed 1997 Adis International Auckland NZ 1642
7. JR Thornton MS Losowsky Opioid peptides and primary biliary cirrhosis Br Med J 297 1988 1501 1504
8. M Michel G Bolger B-A Weissman Binding of a new opiate antagonist, nalmefene, to rat brain membranes Methods Find Exp Clin Pharmacol 7 1985 175 177
9. R Dixon J Howes J Gentile H-B Hsu J Hsiao D Garg Nalmefene: intravenous safety and kinetics of a new opioid antagonist Clin Pharmacol Ther 39 1986 49 53
10. TJ Gal C DiFarzio R Dixon Prolonged blockade of opioid effect with oral nalmefene Clin Pharmacol Ther 40 1986 537 542
11. NV Bergasa JM Schmitt TL Talbot DW Alling MG Swain M Turner Open label trial of oral nalmefene therapy for the pruritus of cholestasis Hepatology 27 1998 679 684
12. TL Talbot JM Schmitt NV Bergasa EA Jones EC Walker Application of piezo film technology for the quantitative assessment of pruritus Biomed Instrum Technol 25 1991 400 403
13. H Koenigstein Experimental study of itch stimuli in animals Arch Dermatol Syphylol 57 1948 828 849
14. DA Thomas GM Williams K Iwata DJ Kenshalo R Dubner Effects of central administration of opioids on facial scratching in monkeys Brain Res 585 1992 315 317
15. NV Bergasa DW Alling J Vergalla EA Jones Cholestasis in the male rat is associated with naloxone-reversible antinociception J Hepatol 20 1994 85 90
16. JE Morley AS Levine Stress-induced eating is mediated through endogenous opiates Science 209 1980 1259 1261
17. FHJ Wolfhagen E Sternieri WCJ Hop G Vitale M Bertolotti HR van Buuren Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study Gastroenterology 113 1997 1264 1269
18. JE Mitchell Naltrexone and hepatotoxicity [letter] Lancet 1 1986 1215